These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19464124)

  • 1. Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?
    Perut V; Labalette C; Sogni P; Ferrand I; Salmon-Céron D; Vidal-Trecan G
    Drug Alcohol Depend; 2009 Sep; 104(1-2):78-83. PubMed ID: 19464124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.
    Schiavini M; Angeli E; Mainini A; Zerbi P; Duca PG; Gubertini G; Vago L; Fociani P; Giorgi R; Cargnel A
    HIV Med; 2006 Jul; 7(5):331-7. PubMed ID: 16945079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with the development of cirrhosis in patients with HCV chronic infection.
    Dinis-Ribeiro M; Ramalho F; Glória H; Marinho R; Raimundo M; Serejo F; Velosa J; Carneiro-de-Moura M
    Hepatogastroenterology; 2005; 52(61):176-9. PubMed ID: 15783023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area.
    Mariano A; Caserta C; Pendino GM; Vacalebre C; Surace P; Fiorillo MT; Polito I; Surace M; Alicante S; Amante A; Foti G; Marra M; Gutamo G; Amato F; Messineo A; Mele A
    Dig Liver Dis; 2009 Jul; 41(7):509-15. PubMed ID: 19196557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid use disorder in the United States: insurance status and treatment access.
    Becker WC; Fiellin DA; Merrill JO; Schulman B; Finkelstein R; Olsen Y; Busch SH
    Drug Alcohol Depend; 2008 Apr; 94(1-3):207-13. PubMed ID: 18222051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for hepatitis C virus infection among current injection drug users in Australia.
    Matthews G; Kronborg IJ; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
    Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
    Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human cytomegalovirus co-infection in patients with chronic viral hepatitis B and C: a comparison of clinical and histological aspects.
    Bayram A; Ozkur A; Erkilic S
    J Clin Virol; 2009 Jul; 45(3):212-7. PubMed ID: 19497785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
    Stroffolini T; Sagnelli E; Mele A; Cottone C; Almasio PL;
    J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.